Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT03711604
Title Compassionate Use Study of Tenalisib (RP6530)
Recruitment Completed
Gender both
Phase Phase Ib/II
Variant Requirements No
Sponsors Rhizen Pharmaceuticals SA
Indications
Therapies
Age Groups: adult | child | senior
Covered Countries USA | POL


No variant requirements are available.